Position in VTRS
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$776,262
+$115,853 QoQ
Shares Held
48,883
0.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#349
of 1,016 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026DNB Asset Management AS holds $45,753,224 across 11 Drug Manufacturers - Specialty & Generic names. VTRS ranks #7 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
120,337 | $20,281,597 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
245,245 | $8,308,900 | |
| 3 | ZTS |
Zoetis Inc.
|
101,556 | $7,297,814 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
8,646 | $4,684,662 | |
| 5 | HIMS |
Hims & Hers Health, Inc.
|
55,147 | $1,911,946 | |
| 6 | ALKS |
Alkermes plc.
|
20,328 | $1,065,187 | |
| 7 | VTRS |
Viatris Inc
This page
|
48,883 | $776,262 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
24,879 | $612,272 |
All Filings in VTRS
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $776,262 | 48,883 | Shares | Other | 2026-08-11 | |
| 2026-03-31 | $660,409 | 48,883 | Shares | Other | 2026-05-14 | |
| 2025-12-31 | $163,767 | 13,154 | Shares | Other | 2026-02-05 | |
| 2025-09-30 | $130,224 | 13,154 | Shares | Other | 2025-11-12 | |
| 2025-06-30 | $117,465 | 13,154 | Shares | Other | 2025-08-12 | |
| 2025-03-31 | $1,779,165 | 204,267 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $2,655,124 | 213,263 | Shares | Other | 2025-02-12 | |
| 2024-09-30 | $2,317,379 | 199,602 | Shares | Other | 2024-11-12 | |
| 2024-06-30 | $2,095,300 | 197,112 | Shares | Other | 2024-07-05 | |
| 2024-03-31 | $2,001,323 | 167,615 | Shares | Other | 2024-04-12 | |
| 2023-12-31 | $3,201,553 | 295,619 | Shares | Other | 2024-01-04 | |
| 2023-09-30 | $2,964,645 | 300,674 | Shares | Other | 2023-10-13 | |
| 2023-03-31 | $2,559,122 | 266,021 | Shares | Other | 2023-04-20 | |
| 2022-12-31 | $3,303,172 | 296,781 | Shares | Other | 2023-01-12 | |
| 2022-09-30 | $2,596,299 | 304,730 | Shares | Other | 2022-10-11 | |
| 2022-06-30 | $2,995,781 | 286,130 | Shares | Other | 2022-07-08 | |
| 2022-03-31 | $3,040,078 | 279,419 | Shares | Other | 2022-04-08 | |
| 2021-12-31 | $3,596,788 | 265,838 | Shares | Other | 2022-01-12 | |
| 2021-09-30 | $2,932,843 | 216,446 | Shares | Other | 2021-10-15 | |
| 2021-06-30 | $3,023,621 | 211,590 | Shares | Other | 2021-07-06 | |
| 2021-03-31 | $2,701,881 | 193,406 | Shares | Other | 2021-04-15 | |
| 2020-12-31 | $7,405,410 | 395,166 | Shares | Other | 2021-01-19 | |
| No filing history on record for this holder in this stock. | ||||||